Patient handout

Brain Abscess (Pyogenic)

PRODUCTION

1. Your condition

This handout is for brain abscess (pyogenic). Your care team identified this based on: new persistent headache + focal deficit (~40% — bodilsen cid 2024 pmid 37946527; classic triad only ~22% complete).

Other reasons your team may use this plan: fever + focal neurological deficit / new seizure / ams — pivot to brain-abscess workup (escmid 2024 pmid 37648062); new seizure in patient with otitis / sinusitis / dental / endocarditis / immunocompromise / post-neurosurgical context; post-neurosurgical fever + new deficit — empiric carbapenem + vancomycin pending imaging (escmid 2024 pmid 37648062).

2. Your medications

Take these medications exactly as prescribed. Do not stop or change a dose without talking to your provider.

Medication	Starting dose	How	When	What it does
ceftriaxone	2 g IV q12h	IV	q12h	ESCMID 2024 PMID 37648062 strong/moderate — 3rd-gen cephalosporin covers Streptococcus anginosus group + Streptococcus + most Enterobacterales; high CNS penetration; q12h for CNS dosing (vs q24h for routine bacteremia)
metronidazole	500 mg IV q8h (or 15 mg/kg IV load then 7.5 mg/kg q6h)	IV	q8h	ESCMID 2024 PMID 37648062 strong/moderate — covers Bacteroides + Fusobacterium + Prevotella; essential for odontogenic + otogenic + sinogenic sources (Bodilsen CID 2024 PMID 37946527 oral-cavity polymicrobial 41%); excellent CNS penetration

Plan: Brain-abscess empiric + targeted regimen — ESCMID 2024 (Bodilsen Clin Microbiol Infect PMID 37648062) ladder by host + source

4. When to seek emergency care

Call 911 or go to the nearest emergency room right away if you have:

GCS ≤8 at presentation or decline (ESCMID 2024 PMID 37648062)(life-threatening)
Abscess rupture into ventricular system on imaging (Bodilsen/Eriksen CID 2026 PMID 40476360)(life-threatening)
Midline shift >5 mm or impending uncal / transtentorial herniation (ESCMID 2024 PMID 37648062)(life-threatening)
Abscess ≥2.5 cm diameter and accessible to neurosurgery (Bodilsen/Eriksen CID 2026 PMID 40476360; UK survey PMID 42081068)
Multi-loculated abscess OR posterior fossa location with brainstem compression / hydrocephalus
Status epilepticus (clinical or electrographic) (ESCMID 2024 PMID 37648062)(life-threatening)
Septic physiology (qSOFA ≥2 / lactate ≥2 / hypotension MAP <65)
HIV CD4 <200 / solid-organ or stem-cell transplant / chronic high-dose corticosteroid / chemotherapy with neutropenia (ESCMID 2024 PMID 37648062)
Otitis media / mastoiditis / cholesteatoma source; temporal lobe or cerebellar abscess; Streptococcus (anginosus group) + anaerobes
Recent dental procedure / dental abscess / poor oral hygiene; frontal lobe abscess; Streptococcus + Fusobacterium + Actinomyces
Sinusitis (especially frontal / sphenoid) source; frontal lobe abscess; Streptococcus + anaerobes
Known / suspected infective endocarditis / IVDU / valvular disease; multiple abscesses; S. aureus + viridans Strep(life-threatening)
Penetrating head trauma / open skull fracture / foreign body; S. aureus + GNR
Recent craniotomy / VP shunt / EVD / deep brain stimulation; S. aureus (incl MRSA) + coag-neg staph + GNR incl Pseudomonas
HIV CD4 <200 / transplant / chemotherapy / chronic high-dose steroid; broad pathogen spectrum including Nocardia + Aspergillus + Mucor + Toxoplasma + TB(life-threatening)
No identifiable source after standard workup (~30% per Bodilsen CID 2024 PMID 37946527); consider PAVM / R-L shunt (Bodilsen 2024 PMID 38064178)

5. Follow-up

OPAT for IV completion if clinically stable + reliable access + ID-OPAT capacity; neurology clinic at 6-8 wk + 6 mo + 12 mo (AED management, neurocognitive battery, return-precautions for late epilepsy ~30%); ID clinic at end-of-therapy; source-control follow-up (dental, ENT, cardiology, pulmonology for PAVM — bubble-echo + chest CT per Bodilsen 2024 PMID 38064178); driving evaluation per jurisdictional regulation

6. Sources

Guideline: ESCMID 2024 guideline on diagnosis and treatment of brain abscess in children and adults (Bodilsen Clin Microbiol Infect 2024;30(1):66-89)